Silence Therapeutics : Condensed consolidated income statement (unaudited) - Form 6-K
Condensed consolidated income statement (unaudited) Three months ended Three months ended March 31, 2024 March 31, 2023 £000s (except per share information) £000s £000s Revenue 12,406 11,374 Cost of sales (2,213 ) (4,534 ) Gross profit 10,193 6,840 …